Literature DB >> 8404187

Pulmonary manifestations in lysinuric protein intolerance.

K Parto1, E Svedström, M L Majurin, R Härkönen, O Simell.   

Abstract

STUDY
OBJECTIVES: To evaluate the pulmonary manifestations and the course of acute respiratory insufficiency associated with lysinuric protein intolerance (LPI).
DESIGN: Retrospective review of clinical data and chest radiographs (total 225) obtained during the lifetime follow-up of 31 LPI patients. About half of the 25 patients without respiratory symptoms underwent high-resolution computed tomography (HRCT) of the lungs, radionuclide perfusion imaging, whole body plethysmography, and diffusing capacity measurements. PATIENTS: Thirty-one Finnish patients with LPI.
RESULTS: During the follow-up period, four children with LPI died in respiratory insufficiency, 1 adult had an episode of respiratory insufficiency, and another had chronic symptoms, whereas 25 patients remained symptom-free. The radiologic findings in acute progressive respiratory insufficiency were uniform: at first, reticulonodular interstitial densities and, later on, progressive airspace disease. At autopsy, three patients showed pulmonary alveolar proteinosis and one had pulmonary hemorrhage and cholesterol granulomas. One adult had reversible respiratory insufficiency with signs of bronchiolitis obliterans, another adult had recurrent episodes of chest pain, dyspnea, and hypoxia. Of the symptom-free patients, one third (8 of 25) had signs suggestive of pulmonary fibrosis evidenced on chest radiographs and two thirds (8 of 14) had signs evidenced by HRCT films. Most symptom-free patients showed mild abnormalities either in perfusion imaging (9 of 12) or in function tests (8 of 12).
CONCLUSION: In childhood, patients with LPI are highly predisposed to develop pulmonary hemorrhages and alveolar proteinosis. Interstitial lung densities may precede the acute phase. Most adult LPI patients show radiologic signs of interstitial lung disease but only a few show clinical impairment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8404187     DOI: 10.1378/chest.104.4.1176

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  26 in total

1.  B and T cell immunity in patients with lysinuric protein intolerance.

Authors:  M Lukkarinen; K Parto; O Ruuskanen; O Vainio; H Käyhty; R M Olander; O Simell
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

Review 2.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

Review 3.  Genetic interstitial lung disease.

Authors:  Megan Stuebner Devine; Christine Kim Garcia
Journal:  Clin Chest Med       Date:  2011-12-06       Impact factor: 2.878

4.  Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis.

Authors:  P Latzin; M Tredano; Y Wüst; J de Blic; T Nicolai; B Bewig; F Stanzel; D Köhler; M Bahuau; M Griese
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

5.  Nutrient intake in lysinuric protein intolerance.

Authors:  L M Tanner; K Näntö-Salonen; J Venetoklis; S Kotilainen; H Niinikoski; K Huoponen; O Simell
Journal:  J Inherit Metab Dis       Date:  2007-06-21       Impact factor: 4.982

6.  Intravenous immune globulin in lysinuric protein intolerance.

Authors:  C Dionisi-Vici; L De Felice; M el Hachem; S Bottero; C Rizzo; A Paoloni; B Goffredo; G Sabetta; M Caniglia
Journal:  J Inherit Metab Dis       Date:  1998-04       Impact factor: 4.982

7.  Immune complex disease consistent with systemic lupus erythematosus in a patient with lysinuric protein intolerance.

Authors:  H Parsons; F Snyder; T Bowen; J Klassen; A Pinto
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

8.  Lysinuric protein intolerance (LPI) gene maps to the long arm of chromosome 14.

Authors:  T Lauteala; P Sistonen; M L Savontaus; J Mykkänen; J Simell; M Lukkarinen; O Simell; P Aula
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

Review 9.  An overview of pulmonary surfactant in the neonate: genetics, metabolism, and the role of surfactant in health and disease.

Authors:  Paul O Nkadi; T Allen Merritt; De-Ann M Pillers
Journal:  Mol Genet Metab       Date:  2009-02-04       Impact factor: 4.797

Review 10.  Interstitial lung disease in infants: new classification system, imaging technique, clinical presentation and imaging findings.

Authors:  Edward Y Lee
Journal:  Pediatr Radiol       Date:  2012-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.